Strategies to Reduce Organic Muscle Atrophy in the Intensive Care Unit
Condition(s):Muscle AtrophyLast Updated:May 5, 2021Withdrawn
Hide Studies Not Open or Pending
Condition(s):Muscle AtrophyLast Updated:May 5, 2021Withdrawn
Condition(s):Neuromuscular Electrical Stimulation; ICU Acquired Muscle WeaknessLast Updated:April 11, 2023Completed
Condition(s):Critical Illness; Muscle Atrophy or WeaknessLast Updated:October 28, 2020Withdrawn
Condition(s):Muscular Atrophy, SpinalLast Updated:December 21, 2023Active, not recruiting
Condition(s):Chronic Obstructive Pulmonary DiseaseLast Updated:March 25, 2015Completed
Condition(s):Chronic Obstructive Pulmonary Disease (COPD)Last Updated:March 18, 2022Terminated
Condition(s):Weakness, MuscleLast Updated:June 17, 2019Unknown status
Condition(s):Covid19; Muscle Atrophy; Muscle WeaknessLast Updated:February 16, 2023Completed
Condition(s):Spinal Muscular AtrophyLast Updated:October 29, 2015Completed
Condition(s):LGMD; LGMDR2; LGMDR1Last Updated:October 24, 2023Enrolling by invitation
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.